AbbVie Inc
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
ABBV$293.30+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| as of December 31 (in millions, except share data) | 2023 | 2022 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and equivalents | $12,814 | $9,201 |
| Short-term investments | 2 | 28 |
| Accounts receivable, net | 11,155 | 11,254 |
| Inventories | 4,099 | 3,579 |
| Prepaid expenses and other | 4,932 | 4,401 |
| Total current assets | 33,002 | 28,463 |
| Investments | 304 | 241 |
| Property and equipment, net | 4,989 | 4,935 |
| Intangible assets, net | 55,610 | 67,439 |
| Goodwill | 32,293 | 32,156 |
| Other assets | 8,513 | 5,571 |
| Total assets | $134,711 | $138,805 |
| Liabilities and Equity | ||
| Current liabilities | ||
| Short-term borrowings | $— | $1 |
| Current portion of long-term debt and finance lease obligations | 7,191 | 4,135 |
| Accounts payable and accrued liabilities | 30,650 | 25,402 |
| Total current liabilities | 37,841 | 29,538 |
| Long-term debt and finance lease obligations | 52,194 | 59,135 |
| Deferred income taxes | 1,952 | 2,190 |
| Other long-term liabilities | 32,327 | 30,655 |
| Commitments and contingencies | ||
| Stockholders' equity | ||
| Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,823,046,087 shares issued as of December 31, 2023 and 1,813,770,294 as of December 31, 2022 | 18 | 18 |
| Common stock held in treasury, at cost, 57,105,354 shares as of December 31, 2023 and 44,589,000 as of December 31, 2022 | (6,533) | (4,594) |
| Additional paid-in capital | 20,180 | 19,245 |
| Retained earnings (accumulated deficit) | (1,000) | 4,784 |
| Accumulated other comprehensive loss | (2,305) | (2,199) |
| Total stockholders' equity | 10,360 | 17,254 |
| Noncontrolling interest | 37 | 33 |
| Total equity | 10,397 | 17,287 |
| Total liabilities and equity | $134,711 | $138,805 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.